Covis Pharma, current maker of the preterm birth drug Makena, has withdrawn it from the market after a US Food and Drug Administration (FDA) panel deemed it ineffective.
Everyone is living with a certain degree of COVID-19-related fear and anxiety at the moment – but spare a thought for the parents of premature and sick babies.
Drug discovery is usually a goal-driven and iterative process, as researchers look for innovative new routes to target particular diseases and study those diseases in afflicted patients to learn ho